Johnson & Johnson-backed HistoSonics seeks valuation of more than $2.5bn
Chances of hospital admission with infectious disease strongly linked to factors such as ethnicity and deprivation, report says
Virologists from 40 countries say year-long US outbreak raises risk that virus will spread between humans
Danish biotech is developing petrelintide in partnership with Swiss pharma group
The FT’s sixth annual ranking by revenue growth. Plus: how healthcare, technology and energy are boosting sales and a deep dive into the Mexican fintech, Canadian oil and the renewables sectors
Companies are keen to offer employees benefits such as fertility treatment and mental health support
Disease could re-establish itself in less than 25 years, Stanford researchers say
A large consensus is forming, not before time
Bowel cancer is projected to become the biggest cause of cancer deaths among young adults by 2030
Sweeping funding cuts threaten to undermine the innovation that has been a central part of US economic strength for decades
Delays to treatment of common women’s health condition criticised by doctors and sufferers
Novartis and Sanofi CEOs push for European benchmark against US prices
Swiss group becomes latest pharmaceutical company to promise investment in the face of potential tariffs
Pharmacies told to stop making custom versions of Wegovy and Zepbound after shortages declared officially over
Gavi says continued support would help American industry as well as save over 1mn lives
Californian researchers and groups such as Precision Neuroscience use implants and AI to make advances in ‘voice prosthesis’
Some are turning to hypnotherapy to treat problem gambling and other financial disorders
Expert tips to optimise your assets, whether you’re prepping for the big day or a hot single summer
Promising late-stage trial results lift US pharmaceutical group’s shares almost 15%
The latest accessory being brandished by twentysomethings is not a designer bag — it’s a made-to-order protein drink in a branded cup
The FT’s resident contrarian tries to make sense of astrology
US pharmaceutical group says patient in study experienced ‘potential drug-induced liver injury’
Amputees, among the largest minority at work, highlight the need for assistive technology to be affordable and accessible
Move comes as government seeks to boost UK’s standing as drugs research leader
Proponents of methods including blood transfusions and gene therapy argue that they can extend longevity. Is it just a delusion?
